Recent Price Movement and Market Context
On 13 Mar 2026, Kopran Ltd’s share price touched an intraday low of Rs.115.65, representing a 5.4% drop on the day and a 3.89% decline compared to the previous close. This marks the third consecutive day of losses, with the stock falling by 7.11% over this period. The stock’s performance today lagged the Pharmaceuticals & Biotechnology sector by 2.08%, while the broader market also faced pressure, with the Nifty closing down 2.06% at 23,151.10 points.
The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend. This technical positioning aligns with the broader market environment, where multiple indices such as Nifty Media, Nifty Realty, and S&P BSE Dollex 30 also hit 52-week lows, and the Nifty Midcap 100 index declined by 2.65%, dragging overall market sentiment lower.
Long-Term Performance and Valuation Metrics
Over the past year, Kopran Ltd’s stock has delivered a negative return of 27.20%, significantly underperforming the Sensex, which posted a modest gain of 1.00% during the same period. The stock’s 52-week high was Rs.214.65, highlighting the extent of the decline from its peak.
Despite its micro-cap status, Kopran’s valuation metrics present a mixed picture. The company’s average Debt to Equity ratio stands at a low 0.23 times, indicating limited leverage. Its Return on Capital Employed (ROCE) for the half-year period is 5.38%, which is relatively low, though the Enterprise Value to Capital Employed ratio of 1.1 suggests the stock is trading at a discount compared to historical peer valuations.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Financial Performance Trends
Kopran Ltd has experienced a decline in operating profit at an annualised rate of 15.89% over the last five years, reflecting subdued growth in its core business. The company has reported negative results for six consecutive quarters, with Profit Before Tax (PBT) excluding other income falling by 22.06% to Rs.10.67 crores in the most recent quarter.
Interest expenses have increased by 27.75% to Rs.2.67 crores, exerting additional pressure on profitability. The company’s ROCE for the half-year period is at a low 5.38%, underscoring challenges in generating returns from capital employed. Over the past year, profits have declined sharply by 65.2%, further weighing on the stock’s performance.
Shareholding and Market Perception
Domestic mutual funds hold a minimal stake of just 0.01% in Kopran Ltd, which may indicate limited institutional confidence in the company’s current valuation or business prospects. Given that domestic mutual funds typically conduct thorough research, their small holding suggests a cautious stance towards the stock.
The stock has underperformed not only in the last year but also over three years and three months relative to the BSE500 index, reflecting persistent challenges in both near-term and long-term performance.
Considering Kopran Ltd? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Pharmaceuticals & Biotechnology + beyond scope
- - Top-rated alternatives ready
Technical Indicators and Market Sentiment
Technical analysis of Kopran Ltd’s stock reveals predominantly bearish signals. The Moving Average Convergence Divergence (MACD) indicator is bearish on both weekly and monthly timeframes. Bollinger Bands also indicate bearish momentum over these periods. The daily moving averages confirm a bearish trend, with the stock trading below all key averages.
Other indicators present a mixed view: the KST (Know Sure Thing) indicator is mildly bullish on a weekly basis but bearish monthly, while Dow Theory signals are mildly bearish on both weekly and monthly charts. The On-Balance Volume (OBV) indicator shows mild bearishness weekly but bullishness monthly, suggesting some divergence in volume trends.
Sector and Market Environment
Kopran Ltd operates within the Pharmaceuticals & Biotechnology sector, which has faced headwinds alongside broader market declines. The Nifty index is trading below its 50-day moving average, though the 50-day average remains above the 200-day average, indicating some underlying resilience in the broader market despite recent volatility.
All market capitalisation segments are experiencing declines, with mid-cap stocks exerting the greatest downward pressure. This challenging environment has contributed to Kopran Ltd’s share price weakness, alongside company-specific factors.
Summary of Key Metrics
To summarise, Kopran Ltd’s stock has reached a new 52-week low of Rs.115.65, reflecting a sustained downtrend amid weak financial results and subdued growth prospects. The company’s micro-cap status, low institutional holding, and bearish technical indicators compound the challenges faced by the stock. While valuation metrics suggest the stock trades at a discount relative to peers, the ongoing decline in profits and returns on capital highlight the difficulties in reversing the current trend.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
